TY  - JOUR
AU  - André, Thierry
AU  - García Carbonero, Rocío
AU  - Díaz, Luis A.
PY  - 2020
DO  - 10.1056/nejmoa2017699
SN  - 0028-4793
UR  - https://hdl.handle.net/20.500.14352/117216
T2  - New England Journal of Medicine
AB  - BACKGROUNDProgrammed death 1 (PD-1) blockade has clinical benefit in microsatellite-instability–high (MSI-H) or mismatch-repair–deficient (dMMR) tumors after previous therapy. The efficacy of PD-1 blockade as compared with chemotherapy as first-line...
LA  - eng
M2  - 2207
PB  - Massachusetts Medical Society
TI  - Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
TY  - journal article
VL  - 383
ER  -